CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 31 filers reported holding CYTEIR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,101,261 | +101.1% | 2,500,444 | +84.1% | 1.75% | +110.2% |
| Q2 2023 | $3,530,927 | +103.6% | 1,358,049 | +42.5% | 0.83% | +144.6% |
| Q1 2023 | $1,734,364 | +3.1% | 952,947 | -6.6% | 0.34% | -1.7% |
| Q4 2022 | $1,683,000 | +34.0% | 1,020,000 | +55.9% | 0.35% | +25.7% |
| Q3 2022 | $1,256,000 | -30.7% | 654,112 | +7.9% | 0.28% | -19.5% |
| Q2 2022 | $1,813,000 | – | 606,248 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,474,572 | $9,329,000 | 7.10% |
| Novo Holdings A/S | 4,840,413 | $18,248,000 | 0.96% |
| RA Capital Management | 3,350,506 | $12,631,000 | 0.28% |
| Avidity Partners Management LP | 1,850,000 | $6,975,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $57,000 | 0.06% |
| Baker Brothers Advisors | 812,640 | $3,064,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 105,091 | $396,000 | 0.02% |
| Evercore Wealth Management, LLC | 146,676 | $553,000 | 0.01% |
| Jump Financial, LLC | 21,300 | $80,000 | 0.00% |
| JANUS HENDERSON GROUP PLC | 1,719,610 | $6,486,000 | 0.00% |